Hemostasis Today

November, 2026
November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Anna Rivera: Hemophilia Management – A Shift from Traditional IV Therapies to Novel Subcutaneous Agents
Jun 2, 2026, 17:55

Anna Rivera: Hemophilia Management – A Shift from Traditional IV Therapies to Novel Subcutaneous Agents

Anna Rivera, Director of Operations at Rx Relief, shared a post on LinkedIn:

“Hemophilia management is undergoing a shift from traditional IV therapies to novel subcutaneous agents.

As these advanced therapies emerge, the clinical pharmacist’s role in protocol development and patient education is vital.”

Stay updated with Hemostasis today.